The overall US market for interventional cardiology products is projected to increase from an estimated $3.3 billion in 2015 to roughly $3.6 billion in 2020, a CAGR of 1.2%, according to a recent report by Medtech Insight. Diagnostic interventional cardiology products will remain the fastest growing segment over the next five years, driven by double-digit growth in intracardiac echocardiography (ICE) and optical coherence tomography (OCT) procedures. Sales of therapeutic interventional cardiology products, which accounted for almost 80% of total interventional cardiology product sales in 2015, will slowly have market shares supplanted by the steadily increasing sales of diagnostic interventional cardiology products over the next half-decade. Exhibit 1 presents the combined market forecast for interventional cardiology products for the years 2015 to 2020.
The stronger growth in diagnostic interventional cardiology product sales comes at some expense to sales of therapeutic interventional devices. In an effort to reduce costs and unnecessary surgical interventions, interventional...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?